Ms Stephanie Pearson

PhD student (Clinical Hearing Sciences)

Steph started her PhD in 2017 exploring the impact of tinnitus and hearing loss on quality of life in adult cancer survivors treated with platinum-based chemotherapy, which is funded by the National Institute for Health Research. Her work focusses on the late-effects caused by chemotherapy years after cancer diagnosis.

Expertise Summary

After completing her BSc in Medical Physiology and Therapeutics, she developed a passion for Cancer Biology and was successfully granted the Harpin Scholarship Award for Cancer Research to study an MSc in Oncology. She has experience in both qualitative research, exploring the link between different age groups and the toxic effects of Tamoxifen in women with breast cancer, in addition to laboratory experience, where she carried out pilot experiments to develop an anti-cancer drug for Acute Myeloid Leukaemia.

Steph enjoys both clinical and laboratory research and aims to bring both skill-sets together to explore both the pharmacology of chemotherapy through to the individual impact this has years on in patients.